In 2025, Abbott Laboratories completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Abbott Laboratories has also provided a category-level breakdown for 9 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022-2019 |
|---|---|---|---|---|
Total Scope 1 | 499,000a | 503,000a | 504,000a | |
Total Scope 2 | ||||
Market-Based | 353,000a | 386,000a | 400,000a | |
Location-Based | 449,000a | 471,000a | 471,000a | |
Total Scope 3 | 6,162,000a | 9,971,000b | 10,665,000c | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 11.257a | 11.9905a | 12.5658a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, the total operational greenhouse gas (GHG) emissions of Abbott Laboratories amounted to 948,000 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Abbott Laboratories decreased by 2.67%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
In 2025, the total Scope 1 emissions of Abbott Laboratories were 499,000 metric tons of CO₂ equivalent (tCO₂e).a
Since 2019, Abbott Laboratories's Scope 1 emissions have decreased by 7.76%, reflecting a declining long-term trend in Scope 1 emissions over time.ad
Compared to the previous year (2024), Abbott Laboratories's Scope 1 emissions remained relatively stable, indicating that Abbott Laboratories's emissions have plateaued with no significant change in its operational footprint.a
In 2025, Abbott Laboratories reported Scope 2 greenhouse gas (GHG) emissions of 353,000 tCO₂e using the market-based method and 449,000 tCO₂e using the location-based method.a
Since 2019, Abbott Laboratories's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have decreased by 10.56%, reflecting a declining long-term trend in Scope 2 emissions over time.ad
Compared to the previous year (2024), Abbott Laboratories's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Abbott Laboratories's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2025, Abbott Laboratories reported its Scope 2 emissions using the market-based method and using the location-based method.a
In 2025, Abbott Laboratories reported 6,162,000 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2025 disclosure of Abbott Laboratories includes a breakdown across 9 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2025, Abbott Laboratories reported total Scope 3 emissions of 6,162,000 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 89.48% of these emissions originated from upstream activities such as purchased goods and capital goods, while 10.52% came from downstream activities like product use, distribution, and end-of-life treatment.a
Compared to the previous year (2024), Abbott Laboratories's Scope 3 emissions decreased by 38.2%, highlighting the company's efforts to lower indirect emissions from its value chain.ab
In 2025, Abbott Laboratories reported emissions for 9 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This partial disclosure allows for some insight into the company's indirect impacts.
In 2025, the largest contributors to Abbott Laboratories's Scope 3 emissions were:a
In 2025, Abbott Laboratories reported Scope 1 greenhouse gas (GHG) emissions of 499,000 tCO₂e and total revenues of USD 44,328 millions. This translates into an emissions intensity of 11.26 tCO₂e per millions USD.a
In 2025, Abbott Laboratories reported a Scope 1 emissions intensity of 11.26 tCO₂e per millions USD. Compared to the peer group median of 3.95, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2025, Abbott Laboratories ranked 24 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Abbott Laboratories among the least efficient performers, with one of the highest emissions intensities in its sector.a
In 2025, Abbott Laboratories reported a total carbon footprint of 7,110,000 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 35.04% decrease compared to 2024, indicating progress in reducing its overall greenhouse gas output.ab
The largest contributor to Abbott Laboratories's total carbon footprint was Scope 3 emissions, accounting for 86.67% of the company's total carbon footprint, followed by Scope 1 emissions at 7.02%.a